Nathan J. Coffey

Statistics

Publications

Citations

1.2K

H-Index

Active since

2015

Affiliations

National Institute on Alcohol Abuse and Alcoholism(Current)

National Institutes of Health

University of Pennsylvania

National Human Genome Research Institute

George Mason University

Nathan J. Coffey is an author at National Institute on Alcohol Abuse and Alcoholism specializing in medicine, pharmacology, and cannabinoid pharmacology.

ORCID

Publications per year

2015–2025

Publications

Crystal Structure of the Human Cannabinoid Receptor CB2

Xiaoting Li, Tian Hua, Kiran Vemuri et al. · Cell · 2019 · 405 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

The key role of NLRP3 and STING in APOL1-associated podocytopathy

Junnan Wu, Archana Raman, Nathan J. Coffey et al. · Journal of Clinical Investigation · 2021 · 135 citations · Full text

Medicine, Molecular Biology, Nephrology +17

Cannabinoid CB1 receptor overactivity contributes to the pathogenesis of idiopathic pulmonary fibrosis

Bernadette R. Gochuico, Malliga R. Iyer, Tony Jourdan et al. · JCI Insight · 2017 · 86 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Cannabinoid‐1 receptor deletion in podocytes mitigates both glomerular and tubular dysfunction in a mouse model of diabetic nephropathy

Tony Jourdan, Joshua K. Park, Zoltán V. Varga et al. · Diabetes Obesity and Metabolism · 2017 · 72 citations · Full text

Medicine, Nephrology, Pharmacology +17

Targeting Peripheral CB1 Receptors Reduces Ethanol Intake via a Gut-Brain Axis

Grzegorz Godlewski, Nathan J. Coffey, Jie Liu et al. · Cell Metabolism · 2019 · 61 citations · Full text

Medicine, Neuroscience, Pharmacology +12

1–5 of 20